舒血宁注射液对介入术后氯吡格雷抵抗患者血小板聚集水平影响临床研究.pdfVIP

of onpIateIet inicaI Shuxueninglnjection CI study in with leveIpatients aggregation afterPCI resistance CIopidogreI ABSTRACT of onplatelet ontheeffectShuxueningInjection Observation 0bjective： PCI· after with resistance levelin clopidogrel aggregationpatients afterPCIofclopidogrel Methods：This selectedpatients experiment inXidianGroupHospital 2012 to2013December resistance．FromSeptember of tothe 50cases patients，accordlng of hospitalized DeDartmentCardiology intotwo treatmentgroup diVided groups，the of1：1wererandomly proportion lntne in patlents controlwith25caseseach，controlgroup andthe group for 1nthe ofWesternMedicineTirofiban，patients routinetreatment basedonroutlne therapy were ShuxueningInjection treatment given group o士 two o土 obserVationgroups ofWesternMedicine，co硼paratiVe treatment leVe1． plateletaggregation thanbe士ore aftertreatment of 1eVel aggregation Result：Twogroupsplatelet treatmentthe p上ate上et reduced p 0．05 ：after treatmentsignificantly inthecontro lowerthanthat was intreatmentgroup aggregation group P O．05 ． leVe上1n canreduce aggregatlon ConcIusion：ShuxuenjngInjection platelet abeneficialsupplement afterPCI，is with resistance Datientsclopidogrel of resistance． clopidogrel therapy reslstance Kevwords：ShuxueningInjection C10pidogrel Plateletaggregation Author：RenQianqian Shuang Tutor：Wang 目 录 引言……………………………………………………………………………………一1 第一部分理论研究…………………………………………………………………．3 一、西医理论研究……………………………………………………………………．3 一 冠心病介入治疗的西医研究现状……………………………………………………．3 二 氯吡格雷抵抗……………………………………………………………………4 二、中医理论研究………………………………………………………………………………．．6 一 祖国医学对冠心病介入治疗认识…………………………………………………．．6 二 银杏叶的功效与主治………………………………………………………………．．7 三、舒血宁注射液简介………………………………………………………………7 第二部分临床研究…………………………………………………………………8 一、病例选择………………………………………………………………………．8 一 入选病例………………………………………………………………………．．8 二 诊断标准………………………………………………………………………．．8 三 纳入病例标准……………………………………………………………………11 四 排除病例标准…………………………………………………………………ll 五 剔除病例标准……………………………………………………………………………11 六 中止、撤出标准…………………………………………………………………．1l 二、研究方法………